In This Section

AACR Virtual Annual Meeting II: Announcement of Free Registration

AACR Virtual Meeting II is available freeRegister Now

Posted May 13, 2020

We are grateful to everyone—including the attendees, speakers, and sponsors—who made the AACR Virtual Annual Meeting I such a success. The historic and groundbreaking two-day virtual meeting attracted more than 61,000 registrants from 140 countries.

The AACR is dedicated to the rapid dissemination of innovative cancer research that has always been the hallmark of our Annual Meetings—and to making that research as widely accessible as possible during this global pandemic. Therefore, we are pleased to announce that access to the AACR Virtual Annual Meeting II (June 22-24) will be made freely available. Details about the Virtual Meeting II are provided below:

  • Registration Required. While access to the meeting will be free to everyone, you will be required to register to view the meeting. Even if you registered to attend the Virtual Meeting I (April 27-28), you will need to register again for Virtual Meeting II. Registration for the meeting will open within the next few weeks; a link to the registration site will be posted to the AACR website when it is available.
  • Full Refunds for In-Person Meeting Registrants. If you were registered to attend the in-person Annual Meeting in San Diego and have not yet requested a refund, you will receive an e-mail from Compusystems (the AACR’s Annual Meeting registration partner) within 24 hours that will provide you with refund options and instructions.
  • Meeting Program. The AACR Virtual Annual Meeting II will feature an Opening Plenary Session that explores the range of impactful cancer research and its clinical translation; award lectures from individuals who have made extraordinary contributions to the cancer field; a special presentation from National Cancer Institute Director Ned Sharpless, MD; more than 70 educational sessions and methods workshops; and more than 4,000 proffered papers presented in minisymposia and on an e-poster website. A preliminary list of session titles is currently available through the AACR website; the complete schedule will be available by Tuesday, May 26.
  • Release of Proffered Papers
    Clinical Plenary Sessions: The titles of the proffered papers scheduled for presentation in these sessions will be posted at 12:01 a.m. EDT on Friday, May 15, and the abstracts of these proffered papers will be posted at 12:01 a.m. EDT on Monday, June 22.
    Minisymposia and Special Sessions: The titles and abstracts of all other proffered papers scheduled for presentation in the Virtual Meeting II will be posted at 12:01 a.m. EDT on Friday, May 15.
    E-Posters: The e-posters will be made available at 9:00 a.m. EDT on Monday, June 22, the first day of the meeting.
  • CME Accreditation. The AACR Virtual Annual Meeting II has been approved for AMA PRA Category 1 Credit ™.

We look forward to your participation in the AACR Virtual Annual Meeting II, and we hope that you will consider a donation to the AACR to support our efforts to turn lifesaving science into patient care. Please stay safe and well during this challenging time.

AACR Annual Meeting 2020 Update: Decision to Hold a Virtual Format Only

Posted April 6, 2020

The American Association for Cancer Research (AACR) has been closely monitoring the rapid escalation of the COVID-19 pandemic. The health and safety of all Annual Meeting attendees and the patients and communities they serve are the AACR’s highest priorities. Therefore, the AACR Board of Directors has made the decision not to move forward with an in-person Annual Meeting in August, and instead to present segments of the meeting program in two AACR Virtual Annual Meetings:

  • April 27-28, 2020: AACR Virtual Annual Meeting I. As previously announced, this Virtual Meeting will feature a selection of high-impact proffered paper presentations. The program will include a number of clinical trial plenary sessions featuring more than 30 oral presentations along with perspectives on the science behind the clinical trials by expert discussants; clinical trial poster sessions; several minisymposia that showcase basic and translational science; and three New Drugs on the Horizon symposia that include first disclosures of innovative small molecules and biologics that have recently entered phase I clinical trials. Access to AACR Virtual Annual Meeting I will be made freely available. The abstracts of these proffered paper presentations will be posted online at 12:01 a.m. EDT (U.S.) on Monday, April 27.
  • June 22-24, 2020: AACR Virtual Annual Meeting II. The second Virtual Annual Meeting will present thousands of proffered papers in minisymposia and in an e-poster platform. This meeting will also include an exciting Opening Plenary Session with presentations on the latest developments in tumor biology and genetics (including the microenvironment), early detection, precision oncology, and cancer immunotherapies; the Presidential Address; the Presidential Select Symposium on precision pediatric cancer medicine; scientific merit and distinguished public service award lectures from individuals who have made extraordinary contributions to the cancer field; and a comprehensive educational program featuring about 70 educational sessions and methods workshops. Further details on the program, information regarding registration for AACR Virtual Annual Meeting II, and guidance in obtaining any refunds of registration fees for the in-person April 2020 Annual Meeting will be communicated as soon as possible. Abstracts of the proffered paper presentations presented in this Virtual Meeting will be posted online at 12:01 a.m. EDT (U.S.) on Friday, May 15.

The AACR is dedicated to the rapid dissemination of innovative cancer research that has always been the hallmark of our Annual Meetings. We look forward to your participation in AACR Virtual Annual Meetings I and II, during which cutting-edge data from across the full spectrum of cancer science and medicine will be presented by scientists from around the world. Thank you for your support during this challenging global health crisis.

AACR Virtual Annual Meeting 2020: Selected Presentations / Other Free Resources

Posted March 31, 2020

The AACR is planning to reschedule the Annual Meeting for late August while at the same time closely monitoring the developments surrounding COVID-19. An official announcement of the rescheduled meeting will be made in the near future. In an effort to support the cancer research community during this difficult time, we are taking several steps to disseminate innovative cancer science and medicine more widely:

  • AACR Virtual Annual Meeting 2020: Selected Presentations. The AACR received more than 225 clinical trials for presentation at the Annual Meeting. Due to the time-sensitive nature of these trials—many of which are practice-changing—we are making them available to the community at the time of the original April meeting. Therefore, as per our previous announcement, the AACR will host a slate of selected sessions online featuring these cutting-edge data.

    This Virtual Annual Meeting will be held on April 27 and 28, 2020, and will include more than 30 oral presentations in several clinical trial plenary sessions along with commentaries from expert discussants, as well as clinical trial poster sessions consisting of short videos providing the authors’ perspectives. The Virtual Meeting will feature a New Drugs on the Horizon session as well as nine minisymposia that will showcase a broad sample of basic and translational science. Topics will include genomics, tumor microenvironment, novel targets, drug discovery, therapeutics, immunotherapy, biomarkers, and cancer prevention. A special minisymposium titled “Advancing Cancer Research Through an International Cancer Registry” will feature use cases of data available through AACR Project GENIE.

    This Virtual Meeting will be available free to everyone, although attendees will be asked to register to participate. The session and presentation titles for the Virtual Meeting, as well as a link to the registration site, will be posted to the AACR website by Monday, April 13.
  • Release of Abstracts. All of the abstracts scheduled for presentation in the Virtual Meeting—and any other clinical trial abstracts that are scheduled for presentation at the rescheduled meeting—will be posted online on Monday, April 27. All other abstracts that have been accepted for presentation at the rescheduled meeting will be posted online on Friday, May 15.
  • AACR Annual Meeting 2019: Free Webcast Presentations. The complete webcasts of the AACR Annual Meeting 2019 in Atlanta are now available free effective immediately, so that users can review the most compelling science from last year’s meeting.
  • Free Access to AACR Journals. We have opened access to our nine highly esteemed journals effective today through the end of the virtual meeting. Please be sure to visit the AACR journals webpage for journal highlights, and to sign up for eTOC alerts.
AACR Annual Meeting 2020: Update on Rescheduled Meeting in August and Announcement of Virtual Annual Meeting Preview

Posted March 20, 2020

On March 10, 2020, after careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, the Board of Directors of the American Association for Cancer Research (AACR) made the decision to terminate the AACR Annual Meeting 2020, originally scheduled for April 24-29 in San Diego, California, and to reschedule the meeting later this year. We continue to closely monitor the developments surrounding COVID-19, and we wish to inform all of our colleagues around the world that we are planning to reschedule the meeting for August. An official announcement of the dates and location will be made in the near future.

While we look forward to holding an in-person meeting that will give the members of the cancer community an opportunity to present and discuss the implications of their important work, make valued connections, and build collaborations with colleagues around the world, we do understand for both the benefit of the research community and cancer patients that some of the latest developments in the field need to be shared in advance of the rescheduled meeting.

Therefore, we are very pleased to announce that the AACR will hold a Virtual Annual Meeting Preview during the dates of the original meeting. Beginning on Monday, April 27, the AACR will host a slate of online sessions featuring innovative presentations of proffered papers and invited content. The virtual meeting program will include exciting clinical trial data from submitted abstracts as well as basic and translational science selected by the Annual Meeting Scientific Program Committee. We will be sending detailed information about the virtual program soon.

We look forward to your active and expert participation in both the virtual and the in-person Annual Meeting events. We extend our profound thanks to the cancer community and our loyal supporters for their understanding and dedication to the AACR during this challenging time.

AACR Annual Meeting 2020: Notice of Termination and Rescheduling

Posted March 10, 2020
The American Association for Cancer Research (AACR) Board of Directors has made the difficult decision, after careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, to terminate the AACR Annual Meeting 2020, originally scheduled for April 24-29 in San Diego, California. A rescheduled meeting is being planned for later this year.

The AACR has been closely monitoring the rapidly increasing domestic and worldwide developments during the last several weeks related to COVID-19. This evidence-based decision was made after a thorough review and discussion of all factors impacting the Annual Meeting, including the U.S. government’s enforcement of restrictions on international travelers to enter the U.S.; the imposition of travel restrictions issued by U.S. government agencies, cancer centers, academic institutions, and pharmaceutical and biotech companies; and the counsel of infectious disease experts. It is clear that all of these elements significantly affect the ability of delegates, speakers, presenters of proffered papers, and exhibitors to participate fully in the Annual Meeting.

The health, safety, and security of all Annual Meeting attendees and the patients and communities they serve are the AACR’s highest priorities. While we believe that the decision to postpone the meeting is absolutely the correct one to safeguard our meeting participants from further potential exposure to the coronavirus, we also understand that this is a disappointing one for our stakeholders. There had been a great deal of excitement about the meeting, which was expected to be the largest ever AACR Annual Meeting, with more than 7,400 proffered papers, a projected total of 24,000 delegates from 80 countries and more than 500 exhibitors. We recognize that the presentation of new data, exchange of information, and opportunities for collaboration offered by the AACR Annual Meeting are highly valued by the entire cancer research community, and we are investigating options for rescheduling the Annual Meeting in the near future.

We thank all of our stakeholders for their patience and support at this time. Additional information regarding hotel reservation cancellations, registration refunds, and meeting logistics is available on the FAQ page on the AACR website. We will announce the dates and location of the rescheduled AACR Annual Meeting 2020 as soon as they are confirmed. Our heartfelt sympathies go out to everyone impacted by this global health crisis.